Literature DB >> 8551421

Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1.

L von Seidlein1, S G Gillette, Y Bryson, T Frederick, L Mascola, J Church, P Brunell, A Kovacs, A Deveikis, M Keller.   

Abstract

OBJECTIVE: To examine complications and treatment of varicella-zoster virus (VZV) infections in children infected with human immunodeficiency virus type 1 (HIV-1).
METHODS: Cases of VZV infection were identified retrospectively by reports to the department of health services and review of medical charts. The CD4+ cell counts were correlated with severity and frequency of VZV episodes.
RESULTS: We identified 117 episodes of VZV infection in 73 HIV-1-infected children between Aug. 21, 1986, and Dec. 1, 1993. The most common complications were recurrence and persistence; 38 children (53%) had 69 recurrent episodes of VZV infection. The majority of children (61%) had zoster during the first recurrent episode, and 32% had a disseminated eruption typical of varicella. There was a strong association between an increasing number of episodes of VZV infection and low CD4+ cell count (p = 0.0008). In a subgroup followed for at least 2 years after their primary varicella episode, 10 of 22 children had a recurrence. Persistence of VZV infection was documented in 10 of 73 children, whereas other complications were rare. Thirty-three children (45%) were hospitalized and received acyclovir intravenously.
CONCLUSION: Primary, recurrent, and persistent VZV infections are a frequent cause of morbidity and hospitalization for HIV-1-infected children. Studies of improved preventive and therapeutic agents are urgently needed in this population.

Entities:  

Mesh:

Year:  1996        PMID: 8551421     DOI: 10.1016/s0022-3476(96)70427-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Varicella zoster infection in HIV-infected children.

Authors:  C Rongkavilit; C D Mitchell; S Nachman
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

2.  Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.

Authors:  Christiane S Eberhardt; Andreas Wieland; Tahseen H Nasti; Alba Grifoni; Elizabeth Wilson; D Scott Schmid; Bali Pulendran; Alessandro Sette; Edmund K Waller; Nadine Rouphael; Rafi Ahmed
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia.

Authors:  Sheng-mei Zhu; Yong-min Liu; Er-dan An; Qing-lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-08       Impact factor: 3.066

4.  A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.

Authors:  Anne A Gershon; Myron J Levin; Adriana Weinberg; Lin-Yee Song; Philip S LaRussa; Sharon P Steinberg; Patterson Bartlett
Journal:  Pediatr Infect Dis J       Date:  2009-07       Impact factor: 2.129

5.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

6.  Persistent detection of varicella-zoster virus DNA in a previously healthy child after severe chickenpox.

Authors:  Mireille T M Vossen; Mi-Ran Gent; Karla M C Peters; Pauline M E Wertheim-van Dillen; Koert M Dolman; Alex van Breda; René A W van Lier; Taco W Kuijpers
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 7.  Chickenpox: treatment.

Authors:  Jonathan Cohen; Judith Breuer
Journal:  BMJ Clin Evid       Date:  2015-06-15

Review 8.  Chickenpox.

Authors:  George H Swingler
Journal:  BMJ Clin Evid       Date:  2007-08-01

9.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

10.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.